Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy)

Journal of Hypertension

Volumn 25, Issue 10, 2007, Pages 2019-2026

  Yui, Yoshiki ^a   Shinoda, Eiji ^b   Kodama, Kazuhisa ^c   Hirayama, Atsushi ^d   Nonogi, Hiroshi ^e   Haze, Kazuo ^f   Sumiyoshi, Tetsuya ^g   Hosoda, Saichi ^g   Kawai, Chuichi ^h   Kawai, C ⁱ   Yui, Y ^i,x   Hosoda, S ⁱ   Iimura, O ⁱ   Ishii, M ^j   Saruta, T ^k   Arakawa, K ^l   Shibata, J ^m   Kanmatsuse, K ^d   Motomiya, T ⁿ   Yabe, Y ^o   Takatsu, F ^p   Haze, K ^q   Minamino, T ^q   Satoh, H ^r   Kodama, K ^x   Hirayama, A ^x   Nonogi, H ^x   Sumiyoshi, T ^x   Shinoda, E ^x   Origasa, H ^s   Kato, K ^t   Nakashima, M ^u   Hattori, R ^v   Morishita, H ^w   more..

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b Rakuyo Hospital   (Japan)

^c Amagasaki Central Hospital   (Japan)

^d NIHON UNIVERSITY   (Japan)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^f OSAKA CITY GENERAL HOSPITAL   (Japan)

^g SAKAKIBARA HEART INSTITUTE   (Japan)

^h TAKEDA GENERAL HOSPITAL   (Japan)

ⁱ Sapporo General Hospital of Hokkaido Railway Company   (Japan)

^j Yokohama Seamen's Hospital   (Japan)

^k KEIO UNIVERSITY HOSPITAL   (Japan)

^l FUKUOKA UNIVERSITY HOSPITAL   (Japan)

^m Asahikawa City Hospital   (Japan)

ⁿ Ohmori Red Cross Hospital

^o TOHO UNIVERSITY   (Japan)

^p ANJO KOSEI HOSPITAL   (Japan)

^q Diagnostic Cardiology and Radiology Department   (Japan)

^r Department of Internal Medicine   (Japan)

^s UNIVERSITY OF TOYAMA   (Japan)

^t Cardiovascular Institute

^u Hamamatsu Institute of Clinical Pharmacology and Therapeutics   (Japan)

^v KINDAI UNIVERSITY NARA HOSPITAL   (Japan)

^w Morishita Cardiovascular Clinic

^x NONE

more..

Author keywords

Angina pectoris; Angiotensin converting enzyme inhibitor; Coronary angiography; Myocardial infarction; Nifedipine retard

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IMIDAPRIL; LISINOPRIL; NIFEDIPINE;

ADULT; ANALYSIS OF VARIANCE; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; JAPAN; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 34748883765     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32829c6908     Document Type: Article

References (22)

1. Cupples LA, Gagnon DR, Wong ND, Ostfeld AM, Kannel WB. Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: the Framingham Study. Am Heart J 1993; 125:863-872.
2. American Heart Association. 2002 Heart and stroke statistical update. Dallas, Texas: American Heart Association; 2001.
3. Hosoda S, Kimata S, Tamura K, Nakamura M, Toshima H, Shibata J, et al. Factors governing re-infarction in patients with myocardial infarction in Japan. Jpn Circ J 1995; 59:130-136.
4. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327:669-677.
5. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342:821-828.
6. Koeber L, Torp-Pederson C, Carlsen JE, Bagger H, Eliason P, Lyngborg K, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333:1670-1676.
7. Ishikawa K, Nakai S, Takenaka T, Kanemasa K, Hama J, Ogawa I, on behalf of the Secondary Prevention Group. Short acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Circulation 1997; 95:2368-2373.
8. The Israeli Sprint Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT): a randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur Heart J 1988; 9:354-364.
9. Goldbourt U, Behar S, Reicher-Reiss H, Zion M, Mandelzweig L, Kaplinsky E. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. Arch Intern Med 1993; 153:345-353.
10. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and caucasians with recent myocardial infarction. Circulation 2000; 101:1102-1108.
11. Kimura E, Kishida H. Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan. Circulation 1981; 63:844-848.
12. Yui Y, Sumiyoshi T, Kodama K, Hirayama A, Nonogi H, Kanmatsuse K, et al. Comparison of nifedipine with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) Randomized Trial. Hypertens Res 2004; 27:181-191.
13. Hollis S, Campbell F. What is meant by intention to treat analysis?: survey of published randomised controlled trials. BMJ 1999; 319:670-674.
14. Shinoda E, Yui Y, Kodama K, Hirayama A, Nonogi H, Haze K, et al. Quantitative coronary angiogram analysis nifedipine versus angiotensin- converting enzyme inhibitors (JMIC-B Side Arm Study). Hypertension 2005; 45:1153-1158.
15. Mancia G, Ruilope LM, Brown MJ, Palmer CR, Rosenthal T, Castaigne A, et al. The effect of nifedipine GITS on outcomes in patients with previous myocardial infarction: a subgroup analysis of the INSIGHT study. Br J Cardiol 2002; 9:401-405.
16. Julis S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trial. Lancet 2004; 363:2022-2031.
17. Ozaki Y, Keane D, Serruys PW. Progression and regression of coronary stenosis in the long-term follow-up of vasospastic angina. Circulation 1995; 92:2446-2456.
18. The ENCORE I Investigators. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease. Circulation 2003; 107:422-428.
19. Motro M, Shemesh J. Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. Hypertension 2001; 37:1410-1413.
20. Simon A, Gariepy J, Moyse D, Levenson J. Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes. Circulation 2001; 103:2949-2954.
21. Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, Riley W. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000; 102:1503-1510.
22. Leenen FHH, Nwachuku CE, Black HR, Cashman WC, Davis BR, Simpson LM, et al. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial. Hypertension 2006; 48:374-384.